Article | April 13, 2026

Navigating High-Potency OSD Manufacturing

Source: Recipharm
GettyImages-2176475661 tabet press, pharma manufacturing

Navigating high‑potency oral solid dose manufacturing requires far more than applying standard OSD approaches at lower exposure limits. As compounds become more potent, risks increase across every stage — from dispensing and processing to packaging and quality control — demanding tighter containment, more deliberate process design, and stronger alignment between development and manufacturing.

This blog explores the key challenges teams face when working with high‑potency OSD products and why early, risk‑based decision‑making is critical to long‑term success. It highlights how closed systems, appropriate equipment selection, and disciplined material handling help protect operators while maintaining product quality and process efficiency. The discussion also considers how scalability, cleaning validation, and regulatory expectations shape practical manufacturing strategies as projects progress toward commercial supply.

For organisations managing increasingly potent pipelines, the piece offers clear perspective on how to balance safety, compliance, and operational flexibility.

Read the full blog to gain insight into making high‑potency OSD manufacturing more predictable and controllable.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Bioprocess Online